Skip to content

    Fairchem Organic

    FAIRCHEMOR
    Chemicals·11 Nov 2025
    Management Summary

    Fairchem Organics faced a challenging Q2 and H1 FY26, with significant declines in revenue, EBITDA, and PAT due to global trade disruptions, U.S. tariffs, and intense competition from Chinese players. Raw material costs remained firm, further compressing margins. The company is focusing on value-added products and new animal feed initiatives, with commercial quantities expected by April-June 2026, but previous guidance for FY25/26 has been withdrawn.

    Highlights

    5
    • Q2 FY26 Revenue from operations stood at INR 112 crores, a 20% decline YoY.

    • EBITDA for Q2 FY26 was INR 4 crores, down 52% YoY, with an EBITDA margin of 3.77%.

    • PAT for Q2 FY26 was INR 0.8 crores, a PAT margin of 0.72%.

    • H1 FY26 Revenue was INR 243 crores, a 20% decline YoY.

    • H1 FY26 EBITDA was INR 9 crores, down 69% YoY, with an EBITDA margin of 3.87%.

    Concerns

    5
    • Revenue declined 20% YoY to INR 112 crores in Q2 FY26 and INR 243 crores in H1 FY26.

    • EBITDA declined 52% YoY to INR 4 crores in Q2 FY26 and 69% YoY to INR 9 crores in H1 FY26.

    • PAT declined significantly by 89% YoY to INR 2 crores in H1 FY26.

    • Imposition of a 50% U.S. tariff on certain Indian chemical products severely impacted export business to the U.S.

    • Aggressive price competition from Chinese suppliers and high raw material costs continue to pressure Dimer Acid margins.

    Key financials

    Metrics

    12

    Periods

    2

    Q2 FY26

    7
    • Revenue
      ₹112 Cr
      YoY-20%
    • EBITDA
      ₹4 Cr
      YoY-52%
    • EBITDA Margin
      3.8%
    • PAT
      ₹0.8 Cr
    • PAT Margin
      72%

    H1 FY26

    5
    • Revenue
      ₹243 Cr
      YoY-20%
    • EBITDA
      ₹9 Cr
      YoY-69%
    • EBITDA Margin
      3.9%
    • PAT
      ₹2 Cr
      YoY-89%
    • PAT Margin
      78%

    Segment breakdown

    Linoleic Acid
    33% Share of Total (Q2 FY26)
    Dimer Acid
    33% Share of Total (Q2 FY26)
    List

    Guidance & targets

    4
    CategoryTargetPriority
    New Product Commercialization
    Animal Feed Product Commercial Quantities
    Start from April-June 2026 quarter
    Medium
    New Product Commercialization
    Animal Feed Product Trial Runs
    December 2025 or January 2026
    Medium
    Margin
    EBITDA Margin
    Double digits
    Low
    Previous Guidance
    FY25/26 Revenue and EBITDA Margin
    No longer valid
    High

    Resolution of U.S. tariff issue for Dimer Acid

    Next quarter / H2 FY26
    Current50% tariff in place, no exports to U.S.
    TargetTariff issue settled, exports to U.S. resume

    Why it matters

    Resolution of tariffs is key to restoring Dimer Acid export volumes and improving overall profitability.

    As far as Dimer Acid is concerned, we are quite hopeful once this U.S. tariff issue settles, we are quite hopeful that we will be substantially exporting Dimer Acid to USA.

    How to verify

    risks_and_concerns[risk='50% U.S. tariff on Indian chemical products']

    Risks & concerns

    7
    RiskSeverity

    Global trade disruptions and competitive intensity

    The quarter continued to be challenging due to global trade disruptions, raw material cost pressure and competitive intensity in the market.Management acknowledged

    high

    50% U.S. tariff on Indian chemical products

    Our performance was directly affected by the imposition of a 50% U.S. tariff on certain Indian chemical products, which includes some of our key offerings, impacting export business to the U.S.Management acknowledged

    high

    Weaker domestic paint sector demand

    The domestic paint sector witnessed weaker demand, leading to lower off-take from one of our major customers.Management acknowledged

    medium

    Aggressive price competition from Chinese suppliers for Dimer Acid

    Our Dimer Acid segment continued to experience margin pressure due to aggressive price competition from Chinese suppliers and no corresponding relief in raw material costs.Management acknowledged

    high

    Regulatory compliance delays for Isostearic Acid exports

    The expected ramp-up in exports to non-U.S. market has been delayed as we work through Regulatory compliance processes mandated by 2 major European producers.Management acknowledged

    medium

    Raw material price volatility and elevated levels

    Even after partial rollback of custom duty, prices remained largely firm due to elevated global vegetable oil market, impacting Dimer Acid margins.Management acknowledged

    high

    Withdrawal of previous financial guidance

    Previous guidance for FY25 and FY26 (INR 1,000 crores top line and 23% EBITDA margin) is no longer valid due to current market conditions.Management acknowledged

    high

    Q&A highlights

    8

    “No. But then the pricing offered by this competitor also has to match with our costing, etc. If the pricing offered by them is not attractive enough for us, then we will not go for that.”

    Highlights that Fairchem is unwilling to compromise on pricing to compete with new entrants, even if it means losing market share with a major customer like Asian Paints.

    asked by Nirag Shah

    2 min read5 chapters

    Detailed Narrative

    01

    Q2 and H1 FY26 Financial Performance Overview

    Fairchem Organics reported a challenging Q2 FY26 with revenue from operations at INR 112 crores, a 20% decline year-on-year. EBITDA for the quarter stood at INR 4 crores, down 52% YoY, resulting in an EBITDA margin of 3.77%. Net profit after tax was INR 0.8 crores, with a PAT margin of 0.72%. For the first half of FY26, revenue was INR 243 crores (down 20% YoY), EBITDA was INR 9 crores (down 69% YoY) with a margin of 3.87%, and PAT was INR 2 crores (down 89% YoY) with a margin of 0.78%.

    02

    Operational Headwinds and Market Challenges

    The company's performance was significantly impacted by global trade disruptions, persistent raw material cost pressure, and intense competitive intensity. A 50% U.S. tariff on certain Indian chemical products, including key offerings, severely affected export business to the U.S., creating near-term uncertainty in international trade flows. Domestically, the paint sector experienced weaker demand, reducing off-take from a major customer.

    03

    Raw Material Dynamics and Chinese Competition

    Despite a partial rollback of additional custom duties, raw material prices remained firm due to elevated global vegetable oil markets. This led to continued margin pressure in the Dimer Acid segment, exacerbated by aggressive price competition from Chinese suppliers. The basic customs duty on imported Dimer Acid remains at 7.5%, allowing Chinese players to compete effectively, even with ocean freight costs, due to unknown export rebates from their government.

    04

    Strategic Focus on Value-Added Products and New Initiatives

    Fairchem continues to focus on its value-added product, Isostearic Acid. However, the ramp-up in exports to non-U.S. markets has been delayed due to regulatory compliance processes mandated by European producers. The company is also developing a new animal feed product, with trial runs expected by December 2025 or January 2026, and commercial quantities anticipated by April-June 2026, targeting exports to Europe and USA.

    05

    Management Transition and Outlook

    Mr. Rajen Jhaveri announced his relinquishment of the CFO and Company Secretary positions effective November 14, 2025, with Mr. Bhavesh Shah taking over as CFO and Mr. Jatin Jain as Company Secretary. The management withdrew its previous guidance of INR 1,000 crores top line and 23% EBITDA margin for FY25/26, stating it no longer holds good. They expressed hope for a return to double-digit EBITDA margins once trade and pricing environments stabilize, and all strategic initiatives align.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.